By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.
Single dose, generally safe and high efficacy,
proven in academic research
Cancer Related Mental Distress: 15 million
Mental Health Sufferers: ~792 million
Pharmacokinetic Study (Phase 1) completion
Q3 2023
Accelerated clinical development strategy
(Real World Evidence)
By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.